PMC:7589163 / 1065-1321
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T6 | 39-50 | Body_part | denotes | fatty acids | http://purl.org/sig/ont/fma/fma82738 |
| T7 | 133-146 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T3 | 133-146 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T5 | 206-215 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T6 | 233-255 | Disease | denotes | respiratory infections | http://purl.obolibrary.org/obo/MONDO_0024355 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 74-75 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 133-146 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T14 | 21-29 | Chemical | denotes | vitamins | http://purl.obolibrary.org/obo/CHEBI_33229 |
| T15 | 39-50 | Chemical | denotes | fatty acids | http://purl.obolibrary.org/obo/CHEBI_35366 |
| T16 | 45-50 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T17 | 55-59 | Chemical | denotes | zinc | http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 233-255 | Phenotype | denotes | respiratory infections | http://purl.obolibrary.org/obo/HP_0011947 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-256 | Sentence | denotes | Supplementation with vitamins, omega 3 fatty acids and zinc appears to be a safe and low-cost way to support optimal function of the immune system, with the potential to reduce the risk and consequences of infection, including viral respiratory infections. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 18 | 31-50 | Chemical | denotes | omega 3 fatty acids | MESH:D015525 |
| 25 | 206-215 | Disease | denotes | infection | MESH:D007239 |
| 26 | 227-255 | Disease | denotes | viral respiratory infections |